Company Profile

Structured around developing and addressing the use of bioengineering human tissues as tools or therapeutics to prevent or cure central nervous system (CNS) disorders, Neurosetts is described as currently melding state of the art biomaterial approaches with novel human neural stem cells derivation protocols to bioengineer brain and spinal cord cells and tissue models in vitro - effectively translating the lab’s innovations for developmental neurotoxicology and drug discovery applications. Describing what the firm is about as "protecting human brain and spinal cord development" Neurosetta is structured around enabling disease modeling and quantitative high-throughput screening designed to uncover risk factors that can perturb neurodevelopment and cause neurological disorders.